微信内可能无法直接打开本站。请点右上角 ··· → 在浏览器打开，或复制链接。
STAT+: The mystery of Moderna’s magic algorithm
RSS 官方收录 · 可信分层展示
关键摘要
Moderna癌症疫苗intismeran获晚期试验成功，首个由算法定制mRNA序列的药物
- Moderna与默沙东联合开发的个性化癌症疫苗晚期试验成功
- 该疫苗intismeran是首个mRNA序列由计算机算法确定的获批药物
- 若获批将标志免疫学、肿瘤生物学与算法医学的重大突破
AI 摘要 · 来源可核验
正文提要
A personalized cancer vaccine developed by Moderna and Merck has generated widespread enthusiasm since the companies announced last week that it had succeeded in a late-stage trial. If regulators ultimately approve it, the treatment will be a triumph of immunology and cancer biology.
But it may also be a triumph of the algorithm.
The vaccine, intismeran autogene, would be the first approved medicine whose genetic instructions — that is, the individual letters of its mRNA — is determined by a computer.